Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3,4-diaminopyridine for Fatigue in Multiple Sclerosis
NCT00342381Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing 3,4-diaminopyridine with Placebo (2 arms). Primary endpoints: Subjective fatigue (Fatigue Severity Scale), Maximal voluntary isometric contraction and 4 more. Started Jun 2006; status: completed.
02
Drugs
amifampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00342381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00342381.